ICN DROPS INTEREST IN HOFFMANN-LA ROCHE

ICN DROPS INTEREST IN HOFFMANN-LA ROCHE

ICN Pharmaceuticals Inc. says it has sold the 8.6 percent stake in Swiss

drug-industry giant

You are only viewing part of an article, please register to get full access.